Treatment Regimens for Immunocompetent Elderly Patients with Primary Central Nervous System Lymphoma: A Scoping Review

Treatment Regimens for Immunocompetent Elderly Patients with Primary Central Nervous System Lymphoma: A Scoping Review

Background: Most patients diagnosed with primary central nervous system lymphoma (PCNSL) are older than 60 years. Despite promising treatment options for younger patients, prognosis for the elderly remains poor and efficacy of available treatment options is limited. Materials and Methods: We conduct...

Full description

Bibliographic Details
Main Authors: Elisabeth Schorb, Lisa Kristina Isbell, Gerald Illerhaus, Gabriele Ihorst, Joerg J. Meerpohl, Kathrin Grummich, Blin Nagavci, Christine Schmucker
Format: Article
Language:English
Published: MDPI AG 2021-08-01
Series:Cancers
Subjects:
primary central nervous system lymphoma
elderly patients
conventional chemotherapy
high-dose chemotherapy
autologous stem cell transplantation
Online Access:https://www.mdpi.com/2072-6694/13/17/4268

Internet

https://www.mdpi.com/2072-6694/13/17/4268

Similar Items